Top 5 Most Read Zoster Articles in 2022
From newsworthy moments to groundbreaking research, these are the most popular articles in the zoster space, published on Pharmacy Times® during 2022.
5. Pfizer, BioNTech Sign New Global Collaboration Agreement for First mRNA-based Shingles Vaccine
This will be the third collaboration between Pfizer and BioNTech in the infectious diseases field, following the influenza vaccine collaboration in 2018 and the COVID-19 vaccine collaboration in 2020. Read More.
4. New Zoster Vaccine Candidates Highlight Moderna mRNA Pipeline
This will increase Moderna’s vaccine catalog to 5, including vaccines against cytomegalovirus (CMV), Epstein-Barr virus (EBV), and HIV, in addition to the immunizations for HSV, and VZV. Read More.
3. Study: Herpesvirus Infection May Increase Risk of Diabetes
Of the 7 herpesviruses examined in the study, herpes simplex virus and cytomegalovirus were associated with incidence of prediabetes and diabetes among individuals with normal glucose tolerance. Read More.
2. 2022 CDC, ACIP Updates to Patient Eligibility for Shingles Vaccination
Unlike the 2022 simplification updates for the hepatitis B and pneumococcal vaccine recommendations, ACIP’s recommendations for patient eligibility for zoster vaccination have become more complicated this year. Read More.
1. Older Adults With Herpes Zoster Have Unique Considerations
Pharmacists can educate older adults on risk factors and prevention efforts around herpes zoster. Read More.
